Skip to content

Clinical trials

Dyslipidemias trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Country / region: Hungary Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20067
20072
20081
20111
20122
20132
20141
20161
20171
20181
20201
20211
20222
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Active, not recruiting2
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda9
Amgen3
AstraZeneca3
Novartis Pharmaceuticals3
89bio, Inc.2
Sanofi2
Arrowhead Pharmaceuticals1
Eli Lilly and Company1
Genentech, Inc.1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias31
Diabetes Mellitus9
Diabetes Mellitus, Type 29
Glucose Metabolism Disorders9
Hyperlipidemias8
Hypercholesterolemia7
Cardiovascular Diseases4
Hypertriglyceridemia4
Atherosclerosis2
Coronary Artery Disease2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.